Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer

Autor Hong Xiang, Abigael G. Chan, Ago Ahene, David I. Bellovin, Rong Deng, Amy W. Hsu, Ursula Jeffry, Servando Palencia, Janine Powers, James Zanghi, Helen Collins
Vydáno 2021-01-01